Severe bleeding caused by piperacillin/tazobactam-induced platelet dysfunction .


Journal

International journal of clinical pharmacology and therapeutics
ISSN: 0946-1965
Titre abrégé: Int J Clin Pharmacol Ther
Pays: Germany
ID NLM: 9423309

Informations de publication

Date de publication:
Aug 2020
Historique:
accepted: 15 07 2020
pubmed: 24 4 2020
medline: 11 11 2020
entrez: 24 4 2020
Statut: ppublish

Résumé

Piperacillin/tazobactam (TZP ) is commonly used against multi-resistant nosocomial A 73-year-old-man experienced severe pulmonary hemorrhage and bloody diarrhea during the treatment with TZP for Platelet dysfunction is a little-known mechanism of TZP-induced bleeding. This is the second reported case of TZP-related bleeding that has been attributed to platelet dysfunction, and the first case report that has not been associated with surgery. While thrombocytopenia is easily recognized, this form of TZP-induced bleeding can be detected only by platelet functional tests.

Identifiants

pubmed: 32324131
pii: 186620
doi: 10.5414/CP203721
doi:

Substances chimiques

Anti-Bacterial Agents 0
Piperacillin, Tazobactam Drug Combination 157044-21-8
Piperacillin X00B0D5O0E

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

454-456

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH